Pharmacy Citation, commencement and interpretation 1 1 These Regulations may be cited as the Council of the Pharmaceutical Society of Northern Ireland (Indemnity Arrangements) Regulations (Northern Ireland) 2022 and shall come into operation on 21st November 2022. 2 In these regulations— “ appropriate cover ” has the meaning assigned to it in Article 11A(3) of the 1976 Order; “ indemnity arrangement ” has the meaning assigned to it in Article 11A(2) of the 1976 Order; “ the 1976 Order ” means the Pharmacy (Northern Ireland) Order 1976; and “ the secretary ” means the secretary of the Statutory Committee. Indemnity arrangements 2 A person seeking to be registered (including on an application for restoration) must declare in writing, at the time of the application for their name to be entered in or restored to the register, that that person— a has in operation, or will have by the time they begin to practise, an indemnity arrangement which provides appropriate cover in relation to that person; and b will provide, at the request of the registrar, documentary evidence of that indemnity arrangement. 3 A registered person who practises as a pharmaceutical chemist must declare in writing, at the time of the application for their name to be retained in the register, that they have in operation an indemnity arrangement which provides appropriate cover in relation to them and will provide at the request of the registrar documentary evidence of that indemnity arrangement. 4 The registrar may, at any time, require a registered person who practises as a pharmaceutical chemist to submit to the registrar— a documentary evidence that they have in operation an indemnity arrangement which provides appropriate cover; and b such other information as the registrar may reasonably require for the purpose of determining whether the registered person’s indemnity arrangement does provide appropriate cover; within such period as the registrar may determine. 5 The registrar may, at any time, seek confirmation from a third party in relation to a registered person, or any person seeking to be registered, that that person has in operation, or will have in operation by the time they begin to practise, an indemnity arrangement which provides appropriate cover. 6 A registered person who practises as a pharmaceutical chemist must promptly inform the registrar if for any reason they cease to have in operation, in accordance with Article 11A(1) of the 1976 Order, an indemnity arrangement which provides appropriate cover. 7 A registered person who practises as a pharmaceutical chemist must provide, at the request of any person who wishes to access their services, information relating to their indemnity arrangement. 8 Where a decision has been taken under Article 11A(8) of the 1976 Order to refuse to retain a person’s name in the register, or under Article 11A(9)(a) of the 1976 Order to remove a person’s name from the register, the decision does not take effect— a until the time for serving a Notice of Appeal on the secretary in respect of the decision has expired; and b where a Notice of Appeal is served within time, until the date on which the appeal is finally disposed of, or is abandoned or fails by reason of its non-prosecution. Time for serving Notice of Appeal 9 1 Subject to paragraph (2), on receipt of the written statement sent by the registrar under Article 11A(10) of the 1976 Order, the registered person, or applicant as the case may be, (hereafter referred to as “ the appellant ”) must serve a Notice of Appeal on the secretary within 28 days beginning with, and including, the date on which the written statement was sent. 2 Where the secretary considers that it was not reasonably practicable for the Notice of Appeal to be served within 28 days, the secretary may by authorisation in writing extend the time limit for serving the Notice of Appeal. Appeals – other provisions 10 Regulations 14 to 29 of the Council of the Pharmaceutical Society of Northern Ireland (Continuing Professional Development) Regulations (Northern Ireland) 2012 shall apply to an appeal under Article 11A(11) of the 1976 Order as they apply under Article 4A(13) of the 1976 Order. Revocation 11 The Council of the Pharmaceutical Society of Northern Ireland (Indemnity Arrangements) Regulations (Northern Ireland) 2014 are revoked. Sealed with the Common Seal of the Pharmaceutical Society of Northern Ireland on 27th October 2022 (L.S.) Jonathan Patton Vice President of the Council of the Pharmaceutical Society of Northern Ireland Trevor Patterson Chief Executive of the Pharmaceutical Society of Northern Ireland The Department of Health approves the Regulations Sealed with the Official Seal of the Department of Health on 27th October 2022 (L.S.) Phil Rodgers A senior officer of the Department of Health